Percheron Therapeutics Ltd
ASX:PER

Watchlist Manager
Percheron Therapeutics Ltd Logo
Percheron Therapeutics Ltd
ASX:PER
Watchlist
Price: 0.074 AUD Market Closed
Market Cap: 76.7m AUD
Have any thoughts about
Percheron Therapeutics Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-4.5
Current
-7.6
Median
13.3
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-4.5
=
Enterprise Value
64.9m AUD
/
EBITDA
-14.3m AUD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-3.2
2-Years Forward
EV/EBITDA
-2.9
3-Years Forward
EV/EBITDA
-5.1

See Also

Discover More